Clinical Trial Update: Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and feasibility of psilocybin in adults with methamphetamine use disorder; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Stimulant Use Disorder
• Substance Use Disorder
• Substance-related Disorders

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Methamphetamine Use Disorder, Substance-Related Disorders | Phase 1 | Status: ACTIVE_NOT_RECRUITING